Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis 2018 NIDA NIH-18-010 CDC NCHHSTP $990,653
Hepatitis 2018 NIDA 5R01DA040488-03 RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression LATKIN, CARL JOHNS HOPKINS UNIVERSITY MD $658,404
Hepatitis 2018 NICHD 1R01HD092527-01 Antiviral prophylaxis and infant vaccination to prevent perinatal hepatitis B infection JOURDAIN, GONZAGUE INSTITUTE OF RESEARCH AND DEVELOPMENT FR $453,073
Hepatitis 2018 NIDA 1R01DA042982-01A1 The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial HAUKOOS, JASON DENVER HEALTH AND HOSPITAL AUTHORITY CO $652,668
Hepatitis 2018 NIAID 5R01AI110577-04 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $453,213
Hepatitis 2018 NIAID 5UM1AI069503-12 Terry Beirn CPCRA Clinical Trials Unit KAN, VIRGINIA GEORGE WASHINGTON UNIVERSITY DC $4,090,330
Hepatitis 2018 NIAID 5R01AI078881-08 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $531,387
Hepatitis 2018 NIAID 5R01AI123271-02 Development of an HTS Assay for Discovery of HBV cccDNA Inhibitors GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $392,250
Hepatitis 2018 NIAID 5UM1AI069530-12 Johns Hopkins University Kampala-Nanning Clinical Trial Unit FOWLER, MARY JOHNS HOPKINS UNIVERSITY MD $1,256,808
Hepatitis 2018 NHLBI 5R01HL119830-04 TTC39B in Metabolism TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Hepatitis 2018 NIAID 5UM1AI069418-12 Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit LENNOX, JEFFREY EMORY UNIVERSITY GA $2,783,692
Hepatitis 2018 NIAID 5UM1AI069476-11 The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit GRINSZTEJN, BEATRIZ FUNDACAO OSWALDO CRUZ BRAZIL $773,601
Hepatitis 2018 NIAID 5UM1AI068616-12 SDMC - IMPAACT Leadership Group SHAPIRO, DAVID HARVARD SCHOOL OF PUBLIC HEALTH MA $6,017,839
Hepatitis 2018 NICHD 5UM1AI068616-12 SDMC - IMPAACT Leadership Group SHAPIRO, DAVID HARVARD SCHOOL OF PUBLIC HEALTH MA $4,327,996
Hepatitis 2018 NIAID 5R01AI116943-03 A systematic analysis of small RNA interactions during RNA virus infections RICE, CHARLES ROCKEFELLER UNIVERSITY NY $706,055
Hepatitis 2018 NIAID 5R01AI122669-03 Optimization of alpha-hydroxytropolones as novel inhibitors of the HBV RNaseH TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $440,118
Hepatitis 2018 NIAID 5UM1AI068632-12 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $14,031,746
Hepatitis 2018 NICHD 5UM1AI068632-12 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $4,659,221
Hepatitis 2018 NCI 5UM1AI068636-12 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,900,000
Hepatitis 2018 NIAID 5UM1AI068636-12 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $50,086,283
Hepatitis 2018 NIDA 5UM1AI068636-12 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Hepatitis 2018 NINDS 5UM1AI068636-12 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Hepatitis 2018 NHLBI 5R01HL127174-03 Canonical & non-canonical regulation of the HDL receptor by PDZK1's PDZ domains KRIEGER, MONTY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $474,167
Hepatitis 2018 NIAID 5R01AI114748-04 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Hepatitis 2018 NIAID 5R21AI127924-02 Ferret cell determinants of hepatitis C virus tropism EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $210,972
Hepatitis 2018 NIDDK 5K08DK099412-04 The role of macrophage migration inhibitory factor in autoimmune hepatitis ASSIS, DAVID YALE UNIVERSITY CT $168,588
Hepatitis 2018 NIAID 5K08AI121348-03 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $199,314
Hepatitis 2018 NIAID 5R37AI047365-19 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Hepatitis 2018 NIAID 5R01AI085051-09 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $588,464
Hepatitis 2018 NIAID 5R01AI108765-05 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $489,206
Hepatitis 2018 NIAID 5R01AI127463-02 Mechanisms of hepatic innate immune activation by HCV GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $613,337
Hepatitis 2018 NIAAA 5P50AA011999-20 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $203,571
Hepatitis 2018 NIMHD 5U01MD010614-03 Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities CARRASQUILLO, OLVEEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $486,084
Hepatitis 2018 NIAID 1R01AI127865-01A1 The role of NLRP6 and DHX15 in control of infection by RNA viruses FIKRIG, EROL YALE UNIVERSITY CT $418,750
Hepatitis 2018 NIGMS 5R01GM116898-03 Function and mechanism of the HCV p7 channel and its therapeutic potential CHOU, JAMES HARVARD MEDICAL SCHOOL MA $462,717
Hepatitis 2018 NHLBI 5K01HL121010-05 The Role of CD8+ T Cells In The Development of Nonalcoholic Fatty Liver Disease KENNEDY, ARION VANDERBILT UNIVERSITY TN $113,004
Hepatitis 2018 NIAID 5U19AI118608-02 7025 Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity LEVY, OFER BOSTON CHILDREN'S HOSPITAL MA $1,007,531
Hepatitis 2018 NIAID 5U19AI118608-02 7027 Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity STEEN, HANNO BOSTON CHILDREN'S HOSPITAL MA $835,849
Hepatitis 2018 NIAID 5U19AI118608-02 7028 Innovative OMIC integration to predict immunogenicity TEBBUTT, SCOTT UNIVERSITY OF BRITISH COLUMBIA CANADA $100,597
Hepatitis 2018 NIAID 5U19AI118608-02 7029 Immune status as a predictor of neonatal vaccine immunogenicity KOLLMANN, TOBIAS UNIVERSITY OF BRITISH COLUMBIA CANADA $100,575
Hepatitis 2018 NIAID 5U19AI118608-02 7030 In vitro modeling to characterize mechanisms of neonatal vaccine induced immune responses LEVY, OFER BOSTON CHILDREN'S HOSPITAL MA $164,146
Hepatitis 2018 NIAID 5R21AI124672-02 Defining approaches for improving HID and HPD compounds as HBV RNaseH antagonists TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $189,375
Hepatitis 2018 NIDDK 5R01DK108357-03 Tissue Responses to Metabolic Stress SCHAFFER, JEAN WASHINGTON UNIVERSITY MO $515,716
Hepatitis 2018 NIAID 5R01AI065256-08 HIV Antiretroviral Therapy and Hepatic Injury SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $500,044
Hepatitis 2018 NIAID 5R01AI123365-03 Structure and function of Hepacivirus envelope glycoprotein LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $625,625
Hepatitis 2018 NIAID 5R01AI124006-03 Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines ROBEK, MICHAEL ALBANY MEDICAL COLLEGE NY $399,750
Hepatitis 2018 NIDA 5R01DA003574-34 Risk Factors for AIDS among Drug Users: Getting Close to Zero DES JARLAIS, DON ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $683,768
Hepatitis 2018 NIAID 5R21AI117128-02 Viral Categorization and Discovery in Acute Liver Failure with Unknown Etiology FAN, XIAOFENG SAINT LOUIS UNIVERSITY MO $189,375
Hepatitis 2018 NIAID 5R01AI099506-05 Modulation of internal ribosome entry by ribosomal protein RPS25 SARNOW, PETER STANFORD UNIVERSITY CA $580,275
Hepatitis 2018 NHLBI 5R01HL105704-07 Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents CHIU, CHARLES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $775,499
Hepatitis 2018 NIAID 5R01AI125365-02 Analyses of the Antiviral and Antifibrotic Mechanisms of Action of NS5A and Cyclophilin Inhibitors GALLAY, PHILIPPE SCRIPPS RESEARCH INSTITUTE CA $481,250
Hepatitis 2018 NICHD 5R01HD075549-05 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $286,572
Hepatitis 2018 NIDDK 5P30DK097948-04 5072 Biorepository Core FIOCCHI, CLAUDIO CASE WESTERN RESERVE UNIVERSITY OH $220,566
Hepatitis 2018 NIAID 5R01AI113923-04 Positive Immune-regulators During Chronic Viral Infections ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $459,066
Hepatitis 2018 NIAAA 5K23AA023753-04 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $199,800
Hepatitis 2018 NCI 5R01CA193244-08 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $365,750
Hepatitis 2018 NIAID 5R01AI114630-04 Innate Immune Response to Hepatocyte Death CRISPE, IAN UNIVERSITY OF WASHINGTON WA $521,263
Hepatitis 2018 NIAAA 5K01AA024174-03 Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease PI, LIYA UNIVERSITY OF FLORIDA FL $145,057
Hepatitis 2018 NIDA 5R01DA039072-04 Life Course Investigation of People Who Inject Drugs BOOTH, ROBERT UNIVERSITY OF COLORADO DENVER CO $539,045
Hepatitis 2018 NIDA 5K01DA036452-05 Social Networks of Youth who Misuse Prescription Opioids and Risk for HIV/HCV AL-TAYYIB, ALIA DENVER HEALTH AND HOSPITAL AUTHORITY CO $151,618
Hepatitis 2018 NIAID 5R01AI110762-03 Molecular Mechanisms of HBV cccDNA Formation GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $393,750
Hepatitis 2018 NIDA 5R01DA016065-15 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $706,389
Hepatitis 2018 NIAID 5R01AI116868-03 Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans RIBEIRO, RUY LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $814,699
Hepatitis 2018 NIAID 5R01AI118933-03 Multimode Observation of Virus Capsid Assembly ZLOTNICK, ADAM INDIANA UNIVERSITY BLOOMINGTON IN $382,886
Hepatitis 2018 NIAID 5R01AI116639-04 Hepatitis B virus vaccine escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL RI $362,250
Hepatitis 2018 NIAID 5R01AI118916-03 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $507,805
Hepatitis 2018 NIAID 5R01AI111970-05 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,096,497
Hepatitis 2018 NIAID 1R01AI134818-01 The Role of HBeAg in HBV Persistence GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $418,840
Hepatitis 2018 NCI 1R01CA222570-01 Serotonergic antidepressants as liver tumor preventives EVASON, KIMBERLEY UNIVERSITY OF UTAH UT $347,510
Hepatitis 2018 NIDDK 1R01DK115987-01 Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH OHLIGER, MICHAEL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $416,408
Hepatitis 2018 NIDA 5R03DA041892-02 Migrant Puerto Rican PWID: The Influence of Acculturation and Enculturation on HIV and HCV Risk Behaviors GELPI-ACOSTA, CAMILA NATIONAL DEVELOPMENT & RES INSTITUTES NY $159,932
Hepatitis 2018 NIDDK 1K23DK115594-01 Noninvasive detection of NASH by magnetic resonance elastography (MRE) ALLEN, ALINA MAYO CLINIC ROCHESTER MN $169,128
Hepatitis 2018 NIAAA 5R01AA017729-07 Innate immune signaling in alcoholic liver disease SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $376,875
Hepatitis 2018 NIDDK 1K01DK115525-01 Hepatocyte PPARgamma regulated mechanisms in NAFLD and lipid homeostasis CORDOBA-CHACON, JOSE UNIVERSITY OF ILLINOIS AT CHICAGO IL $138,021
Hepatitis 2018 NIDDK 5F32DK109658-03 Dissecting the role of hepatic macrophages in progressive NASH KRUGER, ANNIE MASSACHUSETTS GENERAL HOSPITAL MA $67,378
Hepatitis 2018 NIAAA 5K99AA025386-02 Altered Treg differentiation in ALD: a novel role for anaphylatoxins C3a and C5a SMATHERS MCCULLOUGH, REBECCA CLEVELAND CLINIC LERNER COM-CWRU OH $110,939
Hepatitis 2018 NIAID 5R01AI120622-02 RESUBMISSION -R01 AI120622 –Restoration of Immunity and Function with DAA Treatment in HCV infection ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $43,343
Hepatitis 2018 NIDDK 5R01DK074932-12 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Hepatitis 2018 NIAID 5R01AI110358-04 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MED BR GALVESTON TX $387,500
Hepatitis 2018 NCI 5R01CA211794-02 Role of p62/SQSTM1 in obesity-induced liver cancer KARIN, MICHAEL UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $726,246
Hepatitis 2018 NIDDK 5R01DK091538-10 Ketone Body Metabolism and Integrated Metabolic Homeostasis CRAWFORD, PETER UNIVERSITY OF MINNESOTA MN $384,375
Hepatitis 2018 NIAID 5U19AI123862-03 6263 Project 2 - France BAUMERT, THOMAS STANFORD UNIVERSITY CA $216,001
Hepatitis 2018 NIAID 5U19AI123862-03 6262 Humoral immunity against hepatitis C in protected subjects FOUNG, STEVEN STANFORD UNIVERSITY CA $511,706
Hepatitis 2018 NIAID 5U19AI123862-03 6261 Admin Core FOUNG, STEVEN STANFORD UNIVERSITY CA $42,089
Hepatitis 2018 NCI 5R01CA086978-15 Molecular mechanism of diet-induced carcinogenesis JACOB, SAMSON OHIO STATE UNIVERSITY OH $311,850
Hepatitis 2018 NCI 5R01CA168912-05 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI AUGUSTA UNIVERSITY GA $320,588
Hepatitis 2018 NIA 1R01AG055636-01A1 Use of New Hepatitis C Drugs and Patients' Health Outcomes in Medicare JUNG, JEAH PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $472,768
Hepatitis 2018 NIDDK 5F30DK112514-02 Hepatitis C virus cell entry host factor requirements and mechanisms CHAMBERS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $41,724
Hepatitis 2018 NCI 5K99CA215315-02 Regulation of tumor growth and metabolism by hyperinsulinemia PERRY, RACHEL YALE UNIVERSITY CT $148,502
Hepatitis 2018 NIDDK 5R01DK041876-30 Mechanisms of Liver Cell Injury GORES, GREGORY MAYO CLINIC ROCHESTER MN $357,750
Hepatitis 2018 NCI 5R00CA191152-04 Development of mosaic mouse models of HCC for genetic interspecies inference FONT-BURGADA, JOAN RESEARCH INST OF FOX CHASE CAN CTR PA $249,000
Hepatitis 2018 NIDDK 5K08DK101754-05 New Hepatocyte Model Systems to study Hepatitis B Virus Infection SCHWARTZ, ROBERT WEILL MEDICAL COLL OF CORNELL UNIV NY $159,508
Hepatitis 2018 NIDDK 5K08DK111397-02 Mentored Clinical Scientist Research Career Development (K08) research grant IBRAHIM, SAMAR MAYO CLINIC ROCHESTER MN $165,456
Hepatitis 2018 NIDA 5R25DA013582-17 Clinical Addiction Research and Education (CARE) Program SAMET, JEFFREY BOSTON MEDICAL CENTER MA $335,631
Hepatitis 2018 NINR 5F31NR016200-03 Nurse Case Management to Improve Hepatitis C Linkage to Care and Treatment in HIV Coinfection STARBIRD, LAURA JOHNS HOPKINS UNIVERSITY MD $13,883
Hepatitis 2018 NIDA 5R01DA025885-10 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $552,720
Hepatitis 2018 NIDA 1R01DA043815-01A1 Reducing morbidity and mortality from overdose, HIV, and hepatitis C in opioid-using persons BRAITHWAITE, RONALD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $714,928
Hepatitis 2018 NIAID 1R01AI130022-01A1 Hepatitis B virus cccDNA SEEGER, CHRISTOPH RESEARCH INST OF FOX CHASE CAN CTR PA $457,500
Hepatitis 2018 NIAID 5R01AI131685-02 Murine Model of Human Hepatitis A LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $388,750
Hepatitis 2018 NIAID 5R01AI087925-08 Molecular determinants of hepatitis C virus assembly LINDENBACH, BRETT YALE UNIVERSITY CT $418,750
Hepatitis 2018 NIDDK 5R01DK113645-02 Hepatitis C virus infection and mechanism of liver disease progression RAY, RANJIT SAINT LOUIS UNIVERSITY MO $340,875
Hepatitis 2018 NIAID 5R01AI085087-08 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $387,500
Hepatitis 2018 NIDDK 5F31DK112607-02 A critical role for group 3 innate lymphocytes in hepatitis B virus pathogenesis JESPERSEN, JILLIAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $38,882
Hepatitis 2018 NIDDK 5R01DK112295-02 Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV NAGGIE, SUSANNA DUKE UNIVERSITY NC $386,049
Hepatitis 2018 NIDDK 5R01DK104956-04 Molecular Imaging of Liver Fibrosis FUCHS, BRYAN MASSACHUSETTS GENERAL HOSPITAL MA $532,832
Hepatitis 2018 NIGMS 5R35GM118088-03 Enzymes and enzyme complexes in RNA metabolism JANKOWSKY, ECKHARD CASE WESTERN RESERVE UNIVERSITY OH $606,757
Hepatitis 2018 NIAID 5R01AI095690-08 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $380,000
Hepatitis 2018 NIAID 5R01AI131688-02 Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection RICE, CHARLES ROCKEFELLER UNIVERSITY NY $715,770
Hepatitis 2018 NIDDK 5R01DK062777-15 Regulation of Cholesterol Catabolism by Bile Acids KEMPER, JONGSOOK UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $390,640
Hepatitis 2018 NIAID 1R21AI130745-01A1 Heterogeneity in Virus Capsid Assembly and Structure ZUCKERMAN, DANIEL OREGON HEALTH & SCIENCE UNIVERSITY OR $244,781
Hepatitis 2018 NIAID 5U19AI088791-08 6463 Administrative Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $36,604
Hepatitis 2018 NIAID 5U19AI088791-08 6464 Scientific Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $279,636
Hepatitis 2018 NIAID 5U19AI088791-08 6465 Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans RAY, STUART JOHNS HOPKINS UNIVERSITY MD $183,109
Hepatitis 2018 NIAID 5U19AI088791-08 6466 Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $137,360
Hepatitis 2018 NIAID 5U19AI088791-08 6467 Project 3: To define the genetic identity of infecting, superinfecting, and reinfecting strains of HCV and the dynamics of virus elimination, replacement or persistence SHAW, GEORGE UNIVERSITY OF PENNSYLVANIA PA $157,619
Hepatitis 2018 NIDA 5R01DA040513-03 Increasing Involvement of MSM in the Continuum of Care in Kazakhstan WU, ELWIN COLUMBIA UNIV NEW YORK MORNINGSIDE NY $680,687
Hepatitis 2018 NIDDK 5K01DK109025-02 MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease THAPA, MANOJ EMORY UNIVERSITY GA $100,781
Hepatitis 2018 NIAID 1R21AI130815-01A1 Oligonucleotides for Targeted Viral Capsid Protein Destruction DEITERS, ALEXANDER UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $228,843
Hepatitis 2018 NIAID 1R03AI131066-01A1 Spatial and temporal profiling to unravel the host cell responses to hepatitis B virus infection POCHET, NATHALIE BRIGHAM AND WOMEN'S HOSPITAL MA $91,290
Hepatitis 2018 NIAID 5R01AI120733-03 The Impact of HCV Infection on Bone Turnover, Density, and Strength BROWN, TODD JOHNS HOPKINS UNIVERSITY MD $737,374
Hepatitis 2018 NCI 5R01CA186566-04 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $620,205
Hepatitis 2018 NIDDK 5R01DK102883-04 HEPATOCYTE REMODELING BY HEPATITIS C VIRUS RANDALL, GLENN UNIVERSITY OF CHICAGO IL $350,489
Hepatitis 2018 NIDDK 5K08DK101757-05 Optimization and control of hepatocyte activity via biofunctional modification WERTHEIM, JASON NORTHWESTERN UNIVERSITY AT CHICAGO IL $161,748
Hepatitis 2018 NIDDK 5R01DK108743-03 Control of stellate cells-driven liver cancer by the p62/NBR1 adapters MOSCAT, JORGE SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $433,352
Hepatitis 2018 NHLBI 5R01HL119485-05 Novel viruses and viral dynamics in multiple transfusion recipients KAPOOR, AMIT RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $370,989
Hepatitis 2018 NIDDK 5R01DK101579-06 Physiology of Lipid Droplets and Triglyceride Storage FARESE, ROBERT HARVARD SCHOOL OF PUBLIC HEALTH MA $497,727
Hepatitis 2018 NIDDK 5R01DK094652-07 Hepatitis C virus and autophagic response OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis 2018 NIAID 5R01AI097552-05 Role of Lipid Droplets in Hepatitis C Virus Infection OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $477,500
Hepatitis 2018 NIDA 5T32DA041898-02 Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE) DRAINONI, MARI-LYNN BOSTON UNIVERSITY MEDICAL CAMPUS MA $330,443
Hepatitis 2018 NCI 5R01CA188305-04 Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis XIAO, HUA MICHIGAN STATE UNIVERSITY MI $338,033
Hepatitis 2018 NIDA 5R01DA044111-02 Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women KOVACS, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $705,013
Hepatitis 2018 NIDDK 5R01DK106244-03 Hepatitus C virus-induced inflammasome and lipid metabolism WARIS, GULAM ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $351,000
Hepatitis 2018 NIAAA 5R01AA011576-17 Alcohol and Monocyte Signaling SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $376,875
Hepatitis 2018 NIDDK 5F30DK108567-03 The role of SRSF1 in liver function and NASH ARIF, WAQAR UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $49,524
Hepatitis 2018 NIEHS 5F30ES025099-04 Xenobiotic Receptors Modulate PCB-induced Steatohepatitis CLAIR, HEATHER UNIVERSITY OF LOUISVILLE KY $49,524
Hepatitis 2018 NIAAA 5P50AA024333-03 8232 Core C: Clinical Core MCCULLOUGH, ARTHUR CLEVELAND CLINIC LERNER COM-CWRU OH $165,612
Hepatitis 2018 NIAAA 5P50AA024333-03 8234 Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury BROWN, JONATHAN CLEVELAND CLINIC LERNER COM-CWRU OH $219,510
Hepatitis 2018 NIAAA 5P50AA024333-03 8237 Project 4: Innate Immunity and Cell Death in ALD NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $219,508
Hepatitis 2018 NIAID 5R01AI130398-02 Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort BOYD, SCOTT STANFORD UNIVERSITY CA $1,136,944
Hepatitis 2018 NIEHS 5R00ES024455-04 Microcystin-LR toxicity in nonalcoholic steatohepatitis CLARKE, JOHN WASHINGTON STATE UNIVERSITY WA $228,430
Hepatitis 2018 NIDDK 5R01DK100314-04 NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling KOHLI, ROHIT CHILDREN'S HOSPITAL OF LOS ANGELES CA $482,124
Hepatitis 2018 NIGMS 5P20GM113226-03 6168 Administrative Core MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $563,243
Hepatitis 2018 NIGMS 5P20GM113226-03 6172 Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver disease KIRPICH, IRINA UNIVERSITY OF LOUISVILLE KY $151,923
Hepatitis 2018 NIGMS 5P20GM113226-03 6176 Effects of Dietary Fat on the Hepatotoxicity of Environmental Arsenic WATSON, WALTER UNIVERSITY OF LOUISVILLE KY $151,769
Hepatitis 2018 NIDDK 5R01DK106395-03 Metabolic imaging of nonalcoholic fatty liver disease MAYER, DIRK UNIVERSITY OF MARYLAND BALTIMORE MD $448,705
Hepatitis 2018 NIDDK 5R01DK101773-04 Innate Defense Program against HCV SAITO, TAKESHI UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis 2018 NIAID 5R01AI116269-04 Immune correlates of acute HBV recovery with and without HIV THIO, CHLOE JOHNS HOPKINS UNIVERSITY MD $616,491
Hepatitis 2018 NIDA 5K24DA035684-05 Treatment outcomes and comorbidity in HIV-infected IDU LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $164,685
Hepatitis 2018 NIDDK 5R01DK112865-02 Metabolic Origins of Nonalcoholic Steatohepatitis SUNNY, NISHANTH UNIV OF MARYLAND, COLLEGE PARK MD $342,000
Hepatitis 2018 NCI 1F30CA216947-01A1 Investigating the Relationship Between Racial Residential Segregation and Hepatocellular Carcinoma BEMANIAN, AMIN MEDICAL COLLEGE OF WISCONSIN WI $49,524
Hepatitis 2018 NIAAA 1R43AA026473-01 Development of a Human Liver Microphysiological System For Alcoholic Liver Disease PETROPOLIS, DEBORA EMULATE, INC. MA $149,996
Hepatitis 2018 NIAID 2R44AI124933-03 Development of a kit for the targeted depletion of abundant sequencesfromDNA/RNA libraries CARPENTER, MEREDITH ARC BIO, LLC MA $998,921
Hepatitis 2018 NIDDK 5R01DK102850-04 Mechanisms underlying Hepatoprotective Roles of Sestrin2 LEE, JUN HEE UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $348,750
Hepatitis 2018 NCI 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $24,681
Hepatitis 2018 NIMHD 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $7,672
Hepatitis 2018 NHLBI 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $17,091
Hepatitis 2018 NIA 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $2,882
Hepatitis 2018 NIAID 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $90,778
Hepatitis 2018 NICHD 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $7,803
Hepatitis 2018 NIDA 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $12,195
Hepatitis 2018 NIDDK 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $6,538
Hepatitis 2018 NIGMS 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $6,538
Hepatitis 2018 OD 5P30AI036219-24 5313 Clinical Services Core D LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $10,968
Hepatitis 2018 NIDDK 1F32DK116495-01 Protection from NASH development by Hepatic FXR-dependent Regulation of Acute Phase Response ARMSTRONG, LAURA RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS NJ $61,174
Hepatitis 2018 NCI 1F32CA225145-01 Engineering of bacterial probiotics for the detection and treatment of hepatocellular carcinoma SINGER, ZAKARY COLUMBIA UNIV NEW YORK MORNINGSIDE NY $59,038
Hepatitis 2018 NIDDK 5R01DK109823-03 HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression TIEN, PHYLLIS NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $684,328
Hepatitis 2018 NIDDK 5K23DK113220-02 The Growth Hormone and Insulin-like Growth Factor-1 Axis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis DICHTEL, LAURA MASSACHUSETTS GENERAL HOSPITAL MA $198,297
Hepatitis 2018 NIAID 1R01AI136533-01 Dynamics of antigen specific B and Tfh responses during acute and chronic HCV GRAKOUI, ARASH EMORY UNIVERSITY GA $825,277
Hepatitis 2018 NIAAA 5K08AA025112-03 Stearoyl-CoA Desaturase in Alcohol-Promoted Liver Tumorigenesis LAI, KEANE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $195,588
Hepatitis 2018 NIDDK 1R01DK116620-01 TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications TABAS, IRA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $664,138
Hepatitis 2018 NIAAA 5R21AA024550-02 Role of sirtuin 6 in the protection of liver from the alcohol-induced injury DONG, X INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $185,250
Hepatitis 2018 NIAID 5K23AI118584-04 TRIPAI: An innovative way to improve the health of infants by including fathers during prenatal care YEGANEH, NAVA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $202,427
Hepatitis 2018 NIDDK 5R01DK044533-20 Mechanisms of Hepatocyte Transformation by the Hepatitis B Virus X Protein ANDRISANI, OURANIA PURDUE UNIVERSITY IN $346,173
Hepatitis 2018 NIDA 5P30DA040500-04 6227 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Admin Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $298,199
Hepatitis 2018 NIDA 5P30DA040500-04 6228 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Methodology Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $318,183
Hepatitis 2018 NIDA 5P30DA040500-04 6229 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) LINAS, BENJAMIN BOSTON MEDICAL CENTER MA $199,888
Hepatitis 2018 NIDA 5P30DA040500-04 6230 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Dissemination Core) MEISEL, ZACHARY UNIVERSITY OF PENNSYLVANIA PA $271,267
Hepatitis 2018 NIDA 5P30DA040500-04 6231 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Pilot Training Core) ADEN, BRANDON WEILL MEDICAL COLL OF CORNELL UNIV NY $66,368
Hepatitis 2018 NIAID 5R01AI125401-03 Developmental regulation of HBV biosynthesis by FoxA and DNA methylation MCLACHLAN, ALAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $399,750
Hepatitis 2018 NCI 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $64,023
Hepatitis 2018 NIMHD 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $244,794
Hepatitis 2018 NHLBI 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $53,205
Hepatitis 2018 NIA 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $5,212
Hepatitis 2018 NIAID 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $353,810
Hepatitis 2018 NICHD 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $24,220
Hepatitis 2018 NIDA 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $39,977
Hepatitis 2018 NIDDK 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $14,909
Hepatitis 2018 NIGMS 5P30AI050409-20 7296 Core D: Clinical Research Core OFOTOKUN, IGHOVWERHA EMORY UNIVERSITY GA $14,909
Hepatitis 2018 NIDA 5R01DA040811-03 A Natural History Study of Buprenorphine Diversion, Self-Treatment, and Use of Drug Abuse Treatment Services DANIULAITYTE, RAMINTA WRIGHT STATE UNIVERSITY OH $581,500
Hepatitis 2018 NIGMS 5SC1GM111158-04 Biological Studies of alpha-Hydroxytropolones MURELLI, RYAN BROOKLYN COLLEGE NY $392,500
Hepatitis 2018 NIAAA 5F31AA024960-03 A pivotal role for junctional adhesion molecule-A in alcoholic liver injury CHOPYK, DANIEL EMORY UNIVERSITY GA $49,524
Hepatitis 2018 NIDDK 5P01DK057751-18 5096 Expression of the type 3 InsP3 receptor in the injured hepatocyte: mechanisms and effects NATHANSON, MICHAEL YALE UNIVERSITY CT $350,033
Hepatitis 2018 NCI 5R01CA195524-03 Early Detection of Hepatocellular Carcinoma BERETTA, LAURA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $644,934
Hepatitis 2018 NCI 5R01CA198103-03 ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma KAUFMAN, RANDAL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $668,490
Hepatitis 2018 NCI 5U54CA193417-04 7366 Project 1: Mechanisms of Stiffening in Liver Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $331,048
Hepatitis 2018 NIDA 1R34DA045544-01 Development and Pilot Testing of a Persuasive Health Communication Intervention for Emergency Department Patients Who Decline Rapid HIV/HCV Screening MERCHANT, ROLAND BRIGHAM AND WOMEN'S HOSPITAL MA $360,256
Hepatitis 2018 NIAAA 5F32AA024955-03 Role of macrophage migration inhibitory factor in an acutely severe model of alcoholic hepatitis POULSEN, KYLE CLEVELAND CLINIC LERNER COM-CWRU OH $63,034
Hepatitis 2018 NIAAA 5P50AA024337-03 8302 Role of Dietary Fat in Alcoholic Liver Disease MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $68,290
Hepatitis 2018 NIAID 5R01AI127469-02 Molecular and structural characterization of broadly neutralizing anti-HCV antibodies BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $719,898
Hepatitis 2018 NIDA 5R01DA043409-02 Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention HERBECK, JOSHUA UNIVERSITY OF WASHINGTON WA $622,753
Hepatitis 2018 NCI 5UG3CA211551-02 Field-deployable platform for prognostic hepatic cancer screening in low-resource settings PORTER, MARC UNIVERSITY OF UTAH UT $403,427
Hepatitis 2018 OD 5R01DA044135-02 Regulatory T cell dysfunction in HIV-1/HCV drug users LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $199,650
Hepatitis 2018 NIEHS 5R01ES026887-02 Trichloroethene Exposure and Autoimmune Hepatitis KHAN, M. FIROZE UNIVERSITY OF TEXAS MED BR GALVESTON TX $348,750
Hepatitis 2018 NCATS 5KL2TR001441-04 UTMB Clinical and Translational Science Award AMEREDES, BILL UNIVERSITY OF TEXAS MED BR GALVESTON TX $423,431
Hepatitis 2018 NCI 5R01CA190678-04 Mechanisms of obesity-induced hepatocarcinogenesis CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $337,795
Hepatitis 2018 NIAID 1R01AI136626-01 Changes in Bone Quality, Sarcopenia and Fat Distribution in HIV/HCV Patients after HCV Therapy LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $814,787
Hepatitis 2018 NIDDK 5R01DK104735-04 TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITIS FINCK, BRIAN WASHINGTON UNIVERSITY MO $418,815
Hepatitis 2018 NHGRI 5RM1HG009038-03 Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease GELLER, GAIL JOHNS HOPKINS UNIVERSITY MD $1,110,370
Hepatitis 2018 NIDA 1K01DA045618-01A1 Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations PARK, HAESUK UNIVERSITY OF FLORIDA FL $130,041
Hepatitis 2018 NIDA 1K23DA044085-01A1 Engaging Young People who Inject Drugs into HCV and HIV Care ASSOUMOU, SABRINA BOSTON MEDICAL CENTER MA $190,960
Hepatitis 2018 NIAID 1R01AI136715-01 HIV, HCV, Hippo, and Liver Disease Progression CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $792,339
Hepatitis 2018 NIAAA 5R24AA012885-18 Integrative Liver Cell Core TSUKAMOTO, HIDEKAZU UNIVERSITY OF SOUTHERN CALIFORNIA CA $405,793
Hepatitis 2018 NCI 5R21CA209940-02 Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma POCHET, NATHALIE BRIGHAM AND WOMEN'S HOSPITAL MA $175,001
Hepatitis 2018 NIAID 5U19AI082630-10 7590 Restoration of Innate Immunity with Viral Cure CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $481,305
Hepatitis 2018 NIAID 5U19AI082630-10 7591 Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $482,876
Hepatitis 2018 NIAID 5U19AI082630-10 7592 Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy HAINING, WILLIAM DANA-FARBER CANCER INST MA $414,354
Hepatitis 2018 NIAID 5U19AI082630-10 7593 Induction and Recovery of T Cells after Cure of Chronic Viral Infection KLENERMAN, PAUL UNIVERSITY OF OXFORD UK $249,999
Hepatitis 2018 NIAID 5U19AI082630-10 7594 Administrative Core CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $173,225
Hepatitis 2018 NIAID 5U19AI082630-10 7595 Pilot/Feasibility Studies Program CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $84,249
Hepatitis 2018 NIAID 5U19AI082630-10 7596 Tissue and Clinical Core KIM, ARTHUR MASSACHUSETTS GENERAL HOSPITAL MA $284,556
Hepatitis 2018 NIAID 5U19AI082630-10 7597 Virology Core ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $106,547
Hepatitis 2018 NIAID 5K01AI122853-04 Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment Era MARCUS, JULIA HARVARD PILGRIM HEALTH CARE, INC. MA $144,850
Hepatitis 2018 NIAID 5R01AI121315-04 Taking aim at HBV eradication using novel NRTIs and Capsid effectors SARAFIANOS, STEFAN EMORY UNIVERSITY GA $590,494
Hepatitis 2018 NIGMS 5U01GM110749-06 Modeling Epidemic Infectious Diseases Using Sequence Analysis POND, SERGEI TEMPLE UNIV OF THE COMMONWEALTH PA $574,951
Hepatitis 2018 NIMH 5R01MH105319-04 Brain Amyloid and HAND in the cART era ACHIM, CRISTIAN UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $475,752
Hepatitis 2018 FIC 5D43TW009771-05 HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis. MANABE, YUKARI JOHNS HOPKINS UNIVERSITY MD $292,517
Hepatitis 2018 NIDDK 5R01DK112293-02 Fatty liver in HIV infected individuals GAWRIEH, SAMER INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $362,098
Hepatitis 2018 NIMHD 1R01MD012564-01 Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction BLANGERO, JOHN UNIVERSITY OF TEXAS RIO GRANDE VALLEY TX $751,281
Hepatitis 2018 NCI 1R01CA228589-01 Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations SETIAWAN, VERONICA UNIVERSITY OF SOUTHERN CALIFORNIA CA $601,819
Hepatitis 2018 NCI 1R21CA225623-01 Identification of microbial biomarkers for hepatocellular carcinoma in a multi-ethnic population of patients with nonalcoholic fatty liver disease HUSSAIN, SHEHNAZ CEDARS-SINAI MEDICAL CENTER CA $176,514
Hepatitis 2018 NIDA 5R01DA036514-05 Evaluating a Microfinance Intervention for High Risk Women in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $654,246
Hepatitis 2018 NIDA 5R01DA041501-03 The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $739,640
Hepatitis 2018 NIDDK 5F32DK109651-03 Mechanisms of differential susceptibility to nonalcoholic fatty liver disease RIORDAN, JESSE PACIFIC NORTHWEST RESEARCH INSTITUTE WA $7,933
Hepatitis 2018 NIGMS 1SC2GM127206-01 The treatment of Alcohol Liver Disease with Retinoid Beta Agonists TRASINO, STEVEN HUNTER COLLEGE NY $156,000
Hepatitis 2018 NCI 2P01CA022443-41 8184 Project 2 - Mechanisms of Hepatitis B Virus Replication LOEB, DANIEL UNIVERSITY OF WISCONSIN-MADISON WI $387,645
Hepatitis 2018 NCI 2P01CA022443-41 8190 Core C - Virus Core JOHANNSEN, ERIC UNIVERSITY OF WISCONSIN-MADISON WI $76,647
Hepatitis 2018 NIAID 5R01AI113267-06 Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors GUO, JU-TAO BARUCH S. BLUMBERG INSTITUTE PA $537,218
Hepatitis 2018 NIDA 5R37DA013806-19 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $733,577
Hepatitis 2018 NCI 5R01CA206465-03 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer JUSTICE, AMY YALE UNIVERSITY CT $512,833
Hepatitis 2018 NIDA 5R01DA039775-04 Impact of HCV Therapy on CNS Outcomes BHARTI, AJAY UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $419,180
Hepatitis 2018 NIDA 5R01DA040499-04 Antiviral pharmacology and adherence in drug users KISER, JENNIFER UNIVERSITY OF COLORADO DENVER CO $521,567
Hepatitis 2018 NIAID 5R01AI125416-03 Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle HORNER, STACY DUKE UNIVERSITY NC $489,059
Hepatitis 2018 NIEHS 5F31ES028982-02 Polychlorinated biphenyls act through EGFR to worsen NAFLD HARDESTY, JOSIAH UNIVERSITY OF LOUISVILLE KY $30,976
Hepatitis 2018 NIAID 5F32AI126892-03 The role of epistatic networks in shaping adaptive landscapes ACEVEDO, ASHLEY ROCKEFELLER UNIVERSITY NY $61,174
Hepatitis 2018 OD 5R01OD011095-26 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $444,412
Hepatitis 2018 NIAID 5R01AI132833-02 HBV Capsid Effectors SCHINAZI, RAYMOND EMORY UNIVERSITY GA $543,503
Hepatitis 2018 NIAID 5R01AI132213-02 Structure-Based Vaccine Design for Hepatits C Virus FUERST, THOMAS UNIV OF MARYLAND, COLLEGE PARK MD $1,142,860
Hepatitis 2018 NHLBI 5K23HL133358-02 Elucidating Hepatitis C Infection as a Risk Factor for Coronary Heart Disease in HIV-Infected Patients BAGCHI, SHASHWATEE UNIVERSITY OF MARYLAND BALTIMORE MD $182,354
Hepatitis 2018 NIAAA 5K01AA024809-02 Role of Hepatocyte TLR4 in Alcohol-induced Steatohepatitis and Insulin Resistance JIA, LIN UT SOUTHWESTERN MEDICAL CENTER TX $149,472
Hepatitis 2018 NIAID 5K23AI108355-04 Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients VENUTO, CHARLES UNIVERSITY OF ROCHESTER NY $138,978
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer